The small-cap sector mimicked the choppy broad indices and traded little changed Thursday, despite some big moves among individual names.
was one of the biggest winners, surging some 50% to $14.25 after getting listed on the
American Stock Exchange
. The China-based steel concern previously traded on the OTC bulletin board.
Another China-based company,
Orsus Xelent Technologies
, shot up 52% to $4.93 after projecting a year-over-year sales increase of more than 20% in the third quarter. That would mean a top line in excess of $24.6 million for the cell-phone designer.
surged 24% after saying its HE3235 cancer treatment "
significantly inhibited tumor growth
" in preclinical testing on hormone-independent tumors, which are associated with late-stage prostate cancer. Hollis shares were trading at $2.53.
But fellow health-care stock
Bioject Medical Technologies
plunged 23.4% on word
will no longer pursue regulatory approval to use the company's Biojector 2000 with their anti-HIV drug Fuzeon.
Shares of Bioject, Portland, Ore., fell 33 cents to $1.08. Trimeris was recently off 4.8%.
, a San Diego-based women's apparel retailer, sank 10.5% after JPMorgan downgraded the stock in light of
Wednesday night. The analyst said that Wet Seal, a teen-girls' apparel chain, was probably hurt by broad factors such as "tough mall traffic and warmer weather."